Abstract
Get full access to this article
View all access options for this article.
References
1.
Tateishi M.
Drug Metab Rev
1983 ; 14 : 1207 -1234 .
2.
Lock EA
Crit Rev Toxicol
1988 ; 19 : 23 -42 .
3.
Mutti A.
et al. Lancet
1992 ; 340 : (8813 ) 189 -193 .
4.
Buxton PH
,
Hayward M.J.
Neurol
Neurosurg Psychiatry
1967 ; 30 : 511 -518 .
5.
Schaumberg HH
In: Disorders of Central Nervous System. Clinical Neurology Vol. 2. 2 nd edit,
Asbury AK
,
McKhann GM
and
McDonald WI
(eds), pp. 1238 -1249 . Saunders : Philadelphia , 1992 .
6.
Cooper Ajl
et al. J Neurochem
1993 ; 61 : 1731 -1741 .
7.
Mosca M.
et al. FEBS Lett
1994 ; 353 : 21 -24 .
8.
Makar TK
et al. J Neurochem
1994 ; 62 : 1983 -1988 .
9.
Stone TW
Pharmacol
Rev
1993 ; 45 : 309 -379 .
10.
Perry SJ
et al. Mol Pharmacol
1993 ; 43 : 660 -665 .
11.
Perry SJ
et al. FEBS Lett
1995 ; 360 : 277 -280 .